Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Current.
Press releases published on July 7, 2025
ASML reports transactions under its current share buyback program
GlobeNewswire
·
July 7, 2025
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average …
STMicroelectronics Announces Status of Common Share Repurchase Program
GlobeNewswire
·
July 7, 2025
PR N°C3346C STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from June 30, 2025 to July 04, 2025 AMSTERDAM – July 07, 2025 -- STMicroelectronics N.V. (the “Company” or “ …
Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer
GlobeNewswire
·
July 7, 2025
TARPON SPRINGS, Fla., July 7, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor—as …
Vortex Energy Announces ANT Survey Sampling Plan for Robinsons River Salt Project
GlobeNewswire
·
July 7, 2025
VANCOUVER, British Columbia, July 07, 2025 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) is pleased to announce the finalized sampling plan for the Ambient Noise Tomography (ANT) geophysical survey …
UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
GlobeNewswire
·
July 7, 2025
PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has completed …
From Investment to Real Estate: U.S. Accepts Bitcoin for Home Purchases, and LET Mining Helps Asset Growth
GlobeNewswire
·
July 7, 2025
New York City, NY, July 07, 2025 (GLOBE NEWSWIRE) -- As new federal guidelines enable cryptocurrency to qualify as a mortgage asset, U.S. homeowners can now leverage Bitcoin directly in home purchases—with LET Mining poised to support this evolution by …
Medicines for Poland Announces: Without pharmaceutical factories Europe will lose any war
GlobeNewswire
·
July 7, 2025
BRUSSELS, July 07, 2025 (GLOBE NEWSWIRE) -- The need to establish a fund under the EU budget to support the production of critical medicines in Europe is a conclusion drawn from an analysis of the impact of the war on the availability of medicines in …
Onco360 Has Been Selected as a National Specialty Pharmacy for Augtyro™ (repotrectinib)
GlobeNewswire
·
July 7, 2025
LOUISVILLE, Ky., July 07, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has added Augtyro™ (repotrectinib) manufactured by Bristol Myers Squibb to its comprehensive list of limited distribution therapies. Augtyro …
CryptoMiningFirm 2025 Trusted Free Bitcoin Cloud Mining Platform Launches New Mobile App
GlobeNewswire
·
July 7, 2025
San Francisco, California, July 07, 2025 (GLOBE NEWSWIRE) -- In the cryptocurrency space, few platforms have as high a revenue stream as CryptoMiningFirm - and CryptoMiningFirm is one of them. It provides a worry-free, secure, and environmentally friendly …
At the Yacht Club de Monaco nautical prototypes and laboratories come together for the zero emissions goal
GlobeNewswire
·
July 7, 2025
MONACO, July 07, 2025 (GLOBE NEWSWIRE) -- At the Monaco Energy Boat Challenge, new technologies to reach sustainability in the maritime transport sector take center stage with the SeaLab Class and the OpenSea Class. “Vita has been coming to the Monaco …
BTC Miner Announces Million-Dollar Cloud Mining Opportunity After Bitcoin’s Surge
GlobeNewswire
·
July 7, 2025
New York City, NY, July 07, 2025 (GLOBE NEWSWIRE) -- You may have missed the Bitcoin surge, but the opportunity isn’t over. BTC Miner offers you a low-barrier, high-reward investment opportunity where you can easily participate in Bitcoin, Ethereum, and …
Redevances OR annonce les livraisons préliminaires d’onces d’équivalent d’or pour le deuxième trimestre de 2025 et des produits trimestriels et une marge monétaire records
GlobeNewswire
·
July 7, 2025
MONTRÉAL, 07 juill. 2025 (GLOBE NEWSWIRE) -- Redevances OR Inc. (la « Société » ou « Redevances OR ») (TSX et NYSE : OR) a le plaisir de fournir une mise à jour sur ses livraisons, ses produits et sa marge monétaire préliminaires pour le deuxième trimestre …
OR Royalties Announces Preliminary Q2 2025 GEO Deliveries Along with Record Quarterly Revenue & Cash Margin
GlobeNewswire
·
July 7, 2025
MONTRÉAL, July 07, 2025 (GLOBE NEWSWIRE) -- OR Royalties Inc. (“OR Royalties” or the “Company”) (OR: TSX …
Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis
GlobeNewswire
·
July 7, 2025
-- Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91 point placebo-adjusted difference; p=0.0002), compared to patients treated with placebo, establishing new …
Lightchain AI Opens Bonus Round Following $20.9M Raised Across 15 Presale Stages
GlobeNewswire
·
July 7, 2025
SHREWSBURY, United Kingdom, July 07, 2025 (GLOBE NEWSWIRE) -- Lightchain AI, a purpose-built Layer 1 blockchain for artificial intelligence infrastructure, has initiated its Bonus Round token offering after completing 15 successful presale stages and …
BioCryst Appoints Babar Ghias Chief Financial Officer and Head of Corporate Development
GlobeNewswire
·
July 7, 2025
RESEARCH TRIANGLE PARK, N.C., July 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the appointment of Babar Ghias as chief financial officer (CFO) and head of corporate development. Mr. Ghias joins BioCryst from …
Orchard Therapeutics Announces Last Patient Treated in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
GlobeNewswire
·
July 7, 2025
Completion of enrollment achieved nearly one year ahead of schedule Primary analysis anticipated two years post-treatment TOKYO and LONDON and BOSTON, July 07, 2025 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a Kyowa Kirin company, today announced the last …
Boehringer Ingelheim initiates Phase II study of BI 1815368, a potential first-in-class oral treatment for diabetic macular edema
GlobeNewswire
·
July 7, 2025
Ingelheim, Germany, July 7, 2025 – Boehringer Ingelheim today announces the start of the THULITE Phase II clinical study (NCT06962839). It will investigate the efficacy, safety and tolerability of BI 1815368 as a potential oral treatment to improve vision …
OMass Therapeutics to Present New Preclinical Data For its Best-in-Class MC2 Program at ENDO 2025
GlobeNewswire
·
July 7, 2025
Oxford, United Kingdom – 7th July 2025 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces that …
Aya Gold & Silver Reports High-Grade Boumadine Exploration Results, Expands Imariren to 1km and Identifies New High-Grade Asirem Zone to the West
GlobeNewswire
·
July 7, 2025
MONTREAL, July 07, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce new high-grade drill exploration results from its 2025 program at Boumadine in the Kingdom of Morocco. Today's …